BioStar Technology International, LLC FDA Warning (2017)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on April 17, 2017
Executive Summary
The FDA issued a warning letter to BioStar Technology International, LLC on April 17, 2017 citing regulatory violations. Consumers who have purchased products from this company should exercise caution. The letter was issued by Los Angeles District Office.
Detailed Analysis
False Claims and Regulatory Violations
“treatment of rheumatoid arthritis, ulcers, anemia … natural antibiotic and anti-anaphylactic properties.”
“Natural pathogens killer: It kills pathogens by preventing pathogens from replicating … Flus… Heart Disease … Lowering Bad Cholesterol or Low Density Lipoproteins (LDL) … Lowers Blood Pressure … Treats Epstein-Barr Disease … Treats Shingles … Treats Herpes”
“prevent development of diseases such as cancer and other diseases”
Potential Health Risks
“reduction of the risks of diabetes, obesity … reduces insulin levels and increases insulin sensitivity”
Regulatory Context
“arthritis, bacterial infection, bronchitis, fever, flu, gangrene, gonorrhea, hepatitis, herpes, kidney infections, lung infections, strep throat, viral infections … ulcers”
“Section slice of sarcoma tumor in mice … shows the cells in the control group without apotosis and the Angiostop group with apoptosis (tumor died) …”
“ASPARAGUS EXTRACT for HYPERTENSION”
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with BioStar Technology International, LLC?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are BioStar Technology International, LLC products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used BioStar Technology International, LLC products?
- If you have used products from BioStar Technology International, LLC and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter